1Mattu RK,Needham EW,Galton DJ,et al.A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study.Circulation,1995,91:270-274.
2Bruno Baudin.New Aspects On Angiotensin-Converting Enyme:from Gene to Disease,CCIM,2002,42:256.
3Weinberg MS,Wwimberg AJ,Zappe DH.Effiectively targeting the rennin-aagiotensin system in cardiovascular and renal disease rationale for using anglotensin Ⅱ receptor blockers in combination with anglotensin convettng enzyme inhibitors.J Renin Ansioterone Syst,2000,1:217.
4Hunley TE,Julian BA,Phillips JA,et al.Angiotensin converting enzymegene polymorphism:potential silencer motifand impact on progression in IgA nephropathy.Kidney Int,1996,49:571.
5Rigat B,Hubert C,Alhens-Gelas F,et al.An irmertion/deletionpolymorphism in the angiotermin-I-converting enzyme gene accouting for half the variance of serum enzyme levels.J Clin Invest,1990,86:1343.
6Titet L,Rigat B,Visvikis S,et al.Evidence from combined segregation and linkage analysis that a variant of the human angiotensin-converting enzyme gene controls plasma level.Am J Genet,1992,51:197.
7Chowdhury TA,Dronsfield MJ,Kumar S,et al.Examination of two genetic po lymorphisms within the rennin-angiotensin system:no evidence for an association with nephropathy in IDDM.Diabetologia,1996,39:1108.
8Ukkola O,Savolainen MJ,Salmela PI,et al.Insertion/deletion po lymorphism in the angiotensin-converting enzym e gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus.J Mol Med,1995,73:307.
9Jackson A,Brown K,Langdown J,et al.Efect of the angiotensin-converting Enzyme gene deletion polymorphism on the risk of venous thromboembolism.Br J Haematol,2000,111:562.
10Cunnif C,Jones KL,Phillipson J,et al.Ollgohydramnios sequence and renal tubular malfommtion associated with maternal enalapril use.Am J Obstet Gynecol,1990,162:187.
